Type 2 diabetesA prioriA posterioriCurrent guidelines specify hemoglobin A1c (HbA1c) targets around or less than 7.0%, with more (<6.5%) or less (<8%) stringent goals being appropriate for selected patients. The difficulty in setting a precise HbA1c target depends, at least in part, on ...
Current guidelines specify hemoglobin A1c (HbA1c) targets around or less than 7.0%, with more (<6.5%) or less (<8%) stringent goals being appropriate for selected patients. The difficulty in setting a precise HbA1c target depends, at least in part, on the physician perception of the relati...
(HealthDay)—For non-pregnant adults with type 2 diabetes, hemoglobin A1c (HbA1c) targets should be personalized, according to a Clinical Guidelines Synopsis published in the June 19 issue of the Journal of the American Medical Association.
ADDITION-Cambridge was a cluster randomized trial that randomly assigned practices to no screening, screening followed by intensive treatment of screen-detected diabetes (HbA1c target <7.0%, blood pressure target ≤135/85 mm Hg, and cholesterol targets, and low-dose aspirin use unless contraindicated...
机译:设定2型糖尿病的血红蛋白A1c靶点:先验性,后验性或两者都不是? 获取原文 获取原文并翻译 | 示例 获取外文期刊封面目录资料 开具论文收录证明 >> 页面导航 摘要 著录项 相似文献 相关主题 摘要 Current guidelines specify hemoglobin A1c (HbA1c) targets around or less than 7.0 %, with more (< 6.5...
As depicted in Figure 5, not only HbA1c was lowered significantly more and HbA1c targets were achieved in a higher proportion of patients, but also fasting plasma glucose concentrations and body weight were controlled better with long-acting GLP-1 RAs [50]. In addition, the risk of ...
Article Open access 09 November 2023 The trials and tribulations of determining HbA1c targets for diabetes mellitus Article 20 October 2020 Continuous glucose monitoring and intrapersonal variability in fasting glucose Article 08 April 2024 Introduction...
Individualizing therapeutic goals and treatments to meet glycaemic targets safely and without delay remains paramount, in addition to a wider programme of care to reduce cardiovascular risk factors and improve patient outcomes. 展开 关键词: Global Partnership Glycaemic targets HbA1c individualized therapy ...
et al. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes. Nat. Genet. 51, 1137–1148 (2019). This study resolved 3D chromatin contact maps in human islet cells allowing the identification of promoter targets of distal regulatory ...
type 2 diabetes, while reducing the disease's complications. Early combination therapy with two and sometimes three of the DMDs (SGLT2i and GLP-1 RA) and metformin, and lower HbA1c targets (< 6.5%), may halt and even regress the pathological basis of diabetes and improve patient’s ...